现实世界中的淀粉样蛋白 PET 扫描解读与专家意见高度一致
Real-world interpretations of amyloid PET scans demonstrate strong agreement with those of amyloid PET experts
一项新研究显示,社区环境中的影像解读与专家意见高度一致,有助于提升阿尔茨海默病诊断的准确性。研究涉及1,500多份扫描,专家与当地读片者在阳性与阴性结果上的同意率分别为86.6%和91.5%。
研究显示社区环境中的影像解读与专家意见高度一致,有助于提升诊断准确性。
In routine clinical practice, local radiologists and nuclear medicine physicians can reliably interpret amyloid PET scans to aid in the diagnosis and management of Alzheimer's disease, showing good agreement with interpretations by amyloid PET specialists. According to a new study published in The Journal of Nuclear Medicine, local interpretations of nearly 1,500 scans showed excellent agreement with expert panel assessments, demonstrating that visual reads performed in community settings are highly reliable.
The buildup of amyloid plaques in the brain is one of the first signs of Alzheimer's disease. Amyloid-specific PET tracers have been developed to identify this buildup at its earliest stages, revolutionizing how physicians identify and monitor the disease. Today, with the advent of novel disease-modifying therapies and widening reimbursement by third-party payers, amyloid PET is playing an increasing role in the diagnosis and management of patients with suspected Alzheimer's disease.
"For many years, amyloid PET was primarily used in research and clinical trials, and real-world experience was relatively limited," said Gil Rabinovici, M.D., FAAN, FANA, professor of neurology and radiology at the University of California San Francisco. "As amyloid PET becomes more widely used, it's crucial to understand how reliably physicians can interpret the scans in everyday practice."
Rabinovici and colleagues utilized data from the Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) study, which captured more than 18,000 clinical scan interpretations from local radiologists and nuclear medicine physicians in the United States.
A subset of approximately 1,500 scans—consisting of 500 scans for each of the three U.S. Food and Drug Administration–approved tracers, ¹⁸F-florbetaben, ¹⁸F-florbetapir and ¹⁸F-flutemetamol—was assigned to panels of three nuclear medicine physicians or radiologists who are expert in interpreting amyloid PET scans (one panel per tracer) for visual interpretation. The agreement between the local readers and the expert panels was then compared.
Local readers interpreted 60.9% of scans as positive and 39.1% as negative. Across all radiotracers, agreement between majority expert and local reads was good, with 86.6% agreement for positive scans and 91.5% agreement for negative scans. Agreement did not vary significantly by PET tracer, and agreement between individual experts and local readers was also good.
"Our findings highlight the strong agreement between local and expert reads of scans," said Rabinovici. "They are very reassuring, demonstrating that patients and referring clinicians can have confidence in the interpretation of this high-stakes diagnostic test."
Publication details
Konstantinos Chiotis et al., Comparison of Expert Reads Versus Local Clinical Reads of Amyloid PET Scans in the IDEAS Study, Journal of Nuclear Medicine (2026). DOI: 10.2967/jnumed.126.272571
Journal information: Journal of Nuclear Medicine
Key medical concepts
Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Real-world interpretations of amyloid PET scans demonstrate strong agreement with those of amyloid PET experts (2026, November 6) retrieved 6 November 2026 from https://medicalxpress.com/news/2026-11-real-world-amyloid-pet-scans.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com